Michelle Gwon Lan Moy
Physician Assistant · Seattle
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
- Since medical school
- 16 years
- Graduated 2010
Offices
6 locations · Virginia Mason Medical Center · 867 clinicians in this group
Hospitals listed: Virginia Mason Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Michelle Gwon Lan Moy’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A54041 · Cancelled
Licence status: Cancelled · since 1995 · Baylor College of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
2 licences
- Washington PA.PA.60806023Physician Assistant License · since 2017 · expires 2028-03-16ActiveNo board action on this licenceCheck it with the state
- Illinois 085003769Licensed Physician Assistant · since 2010 · expires 2018-03-01Not RenewedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Virginia Mason Medical CenterSeattle, WAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 1.82 (0.23 to 3.4) · 3,535 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.221, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.219, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.222, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 1,760 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Virginia Mason Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 1.82 (0.23 to 3.4) · 3,535 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.221 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.219 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.222 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,760 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.48 (0.73 to 2.23) · 2,812 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.62 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.52 (125.5 to 209.54) · 141 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 158 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 63 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.6 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.7 · 294 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.8 · 231 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 198 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 3,311 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 6,896 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.42) · 7,935 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0.33 to 2.81) · 2,185 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.88 (1.77 to 3.99) · 3,337 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.47 (3.45 to 11.49) · 1,968 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.28 (2.83 to 7.72) · 2,166 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.29 to 3) · 958 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0.04 to 1.1) · 5,502 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 252 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.617 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.759 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 289 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.8 · 407 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 20.7 · 225 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -24.5 · 340 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 17 · 247 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 263 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.6 (4.1 to 7.5) · 469 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.3 (9.1 to 14) · 469 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 221 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 145 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.2 · 95 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (11.1 to 16.8) · 3,595 cases | No different | Jan 2022 – Dec 2024 |
What patients said (486 patients answered, 28% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$4,891
Medicare paid this office $4,891 for 24 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Coronary artery bypass graft (CABG) | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Harvest of vein using an endoscope | – | 22 | 20 | 18 | 18 | – |
| Coronary artery bypass using artery graft, 1 graft | – | 20 | 20 | 20 | 16 | – |
| Coronary artery bypass using vein or artery graft, 2 grafts | – | – | 14 | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
24 Original Medicare patients in 2024. Average age 74 · Also on Medicaid 0% · Health risk score 1.36. Above the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 75% · Coronary heart disease 75% · Heart failure 67% · Atrial fibrillation 54%.
The office billed $26,550, Medicare allowed $6,100 and paid $4,891; for 53 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 24 | 53 | 74 | 1.36 | $26,550 | $4,891 |
| 2023 | 34 | 92 | 74 | 1.35 | $61,869 | $12,207 |
| 2022 | 39 | 107 | 75 | 1.33 | $58,023 | $12,228 |
| 2021 | 29 | 82 | 71 | 1.89 | $43,900 | $8,785 |
| 2020 | 31 | 82 | 73 | 1.51 | $39,406 | $8,499 |
| 2019 | 151 | 180 | 76 | 1.73 | $27,983 | $8,979 |
| 2018 | 239 | 300 | 76 | 1.39 | $43,050 | $16,282 |
| 2014 | 22 | 31 | 71 | 2.17 | $111,845 | $3,712 |
| 2013 | 12 | 23 | 71 | 1.30 | $204,721 | $3,732 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Coronary artery bypass using artery graft, 1 graft | 16 | $3,296 | $206 |
| Harvest of vein using an endoscope | 18 | $32 | $2 |
2022: 2 services
| Coronary artery bypass using artery graft, 1 graft | 20 | $3,780 | $189 |
| Harvest of vein using an endoscope | 18 | $33 | $2 |
2021: 3 services
| Coronary artery bypass using artery graft, 1 graft | 20 | $3,805 | $190 |
| Coronary artery bypass using vein or artery graft, 2 grafts | 14 | $635 | $45 |
| Harvest of vein using an endoscope | 20 | $35 | $2 |
2020: 2 services
| Coronary artery bypass using artery graft, 1 graft | 20 | $4,128 | $206 |
| Harvest of vein using an endoscope | 22 | $43 | $2 |
2019: 3 services
| Return visit (30+ min) | 108 | $5,947 | $51 |
| New patient visit (45+ min) | 18 | $1,502 | $83 |
| Short return visit (20+ min) | 15 | $521 | $35 |
2018: 3 services
| Return visit (30+ min) | 176 | $11,485 | $55 |
| New patient visit (45+ min) | 32 | $2,768 | $87 |
| Short return visit (20+ min) | 24 | $698 | $24 |
Drugs they prescribed that Part D paid
$16,199
Pharmacies billed $16,199 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 11% of their Part D prescriptions (38 of 351) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%.
296 generic and fewer than 11 brand-name prescriptions · $16,199 in drug cost · 18 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 23 | $12,940 | $563 |
| Amiodarone | 17 | $362 | $21 |
| Pantoprazole | 33 | $190 | $6 |
| Oxycodone | 30 | $148 | $5 |
| Clopidogrel | 24 | $138 | $6 |
See all 9 drugs
| Eliquis | 23 | $12,940 | $563 |
| Amiodarone | 17 | $362 | $21 |
| Pantoprazole | 33 | $190 | $6 |
| Oxycodone | 30 | $148 | $5 |
| Clopidogrel | 24 | $138 | $6 |
| Potassium Chloride | 34 | $122 | $4 |
| Famotidine | 11 | $117 | $11 |
| Metoprolol | 23 | $101 | $4 |
| Furosemide | 36 | $65 | $2 |
Year by year
| 2024 | 351 | 77 | 11% (38) | None | $16,199 |
| 2023 | 283 | 57 | 13% (38) | None | $11,457 |
| 2022 | 302 | 73 | 14% (41) | None | $8,587 |
| 2021 | 246 | 70 | 13% (33) | 18% | $16,741 |
| 2020 | 314 | 89 | 5% (14) | 15% | $32,910 |
| 2019 | 529 | 130 | 0% (0) | 27% | $103,955 |
| 2018 | 338 | 108 | 0% (0) | 24% | $45,539 |
| 2017 | 20 | 13 | None | None | $921 |
| 2016 | 75 | 23 | 16% (12) | 16% | $3,583 |
| 2015 | 96 | 21 | 14% (13) | None | $2,183 |
| 2014 | 119 | 32 | 20% (24) | 11% | $4,026 |
| 2013 | 125 | 31 | 21% (26) | None | $5,737 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Eliquis | 13 | $7,499 | $577 |
| Famotidine | 45 | $608 | $14 |
| Amiodarone | 15 | $266 | $18 |
| Oxycodone | 31 | $207 | $7 |
| Potassium Chloride | 25 | $181 | $7 |
| Pantoprazole | 28 | $152 | $5 |
| Clopidogrel | 18 | $143 | $8 |
| Metoprolol | 15 | $107 | $7 |
| Furosemide | 31 | $58 | $2 |
2022: 7 drugs
| Clopidogrel | 43 | $412 | $10 |
| Potassium Chloride | 28 | $289 | $10 |
| Oxycodone | 33 | $273 | $8 |
| Metoprolol | 28 | $184 | $7 |
| Amiodarone | 11 | $181 | $16 |
| Omeprazole | 13 | $99 | $8 |
| Furosemide | 26 | $87 | $3 |
2021: 8 drugs
| Eliquis | 18 | $11,464 | $637 |
| Clopidogrel | 35 | $317 | $9 |
| Amiodarone | 13 | $272 | $21 |
| Potassium Chloride | 18 | $129 | $7 |
| Oxycodone | 23 | $118 | $5 |
| Metoprolol | 18 | $112 | $6 |
| Omeprazole | 19 | $109 | $6 |
| Furosemide | 24 | $47 | $2 |
2020: 10 drugs
| Eliquis | 14 | $11,794 | $842 |
| Metoprolol | 40 | $1,477 | $37 |
| Clopidogrel | 55 | $544 | $10 |
| Amiodarone | 16 | $256 | $16 |
| Atorvastatin | 17 | $236 | $14 |
| Lisinopril | 21 | $113 | $5 |
| Metoprolol | 19 | $92 | $5 |
| Amlodipine Besylate | 13 | $83 | $6 |
| Carvedilol | 11 | $73 | $7 |
| Omeprazole | 12 | $65 | $5 |
2019: 15 drugs
| Eliquis | 71 | $58,322 | $821 |
| Xarelto | 26 | $19,353 | $744 |
| Pradaxa | 21 | $13,907 | $662 |
| Metoprolol | 100 | $2,669 | $27 |
| Atorvastatin | 45 | $821 | $18 |
| Clopidogrel | 29 | $571 | $20 |
| Isosorbide Mononitrate Er | 18 | $521 | $29 |
| Atenolol | 13 | $282 | $22 |
| Amiodarone | 15 | $228 | $15 |
| Carvedilol | 19 | $178 | $9 |
| Lisinopril | 25 | $142 | $6 |
| Losartan | 16 | $139 | $9 |
| Metoprolol | 16 | $117 | $7 |
| Amlodipine Besylate | 11 | $84 | $8 |
| Furosemide | 12 | $62 | $5 |
2018: 9 drugs
| Eliquis | 30 | $20,875 | $696 |
| Xarelto | 13 | $6,996 | $538 |
| Metoprolol | 81 | $1,725 | $21 |
| Flecainide Acetate | 15 | $1,090 | $73 |
| Amiodarone | 22 | $567 | $26 |
| Clopidogrel | 24 | $399 | $17 |
| Diltiazem | 12 | $219 | $18 |
| Atorvastatin | 17 | $219 | $13 |
| Furosemide | 17 | $86 | $5 |
2016: 1 drug
| Furosemide | 12 | $30 | $2 |
2015: 2 drugs
| Furosemide | 18 | $93 | $5 |
| Metoprolol | 13 | $55 | $4 |
2014: 3 drugs
| Hydrocodone-Acetaminophen | 14 | $232 | $17 |
| Metoprolol | 11 | $56 | $5 |
| Furosemide | 11 | $53 | $5 |
2013: 2 drugs
| Hydrocodone-Acetaminophen | 24 | $288 | $12 |
| Isosorbide Mononitrate Er | 13 | $229 | $18 |
Money from drug and device companies
$1,321 in 2024
| 2024 | 2 | 4 | None | $1,321 |
| 2022 | 1 | 1 | None | $88 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Getinge USA Sales | Vasoview Hemopro 2 | $1,147 | 3 payments
|
| Medtronic | Avalus | $174 | 1 payment
|
See all 4 published payments
| Getinge USA Sales | Meals · 2024-12-02 | Vasoview Hemopro 2 | $11 |
| Getinge USA Sales | Meals · 2024-12-02 | Vasoview Hemopro 2 | $37 |
| Getinge USA Sales | Travel · 2024-11-08 | Vasoview Hemopro 2 | $1,099 |
| Medtronic | Meals · 2024-09-17 | Avalus | $174 |
See earlier years (2022)
2022: $88
| Merz North America | None | $88 | 1 payment
|
Professional record
- NPI
- 1851607337
- Licence
- CA 54041, IL 085.003769, WA PA60806023California A54041: CancelledWashington PA.PA.60806023: ActiveIllinois 085003769: Not Renewed
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 1100 9th Ave, Seattle, WA, 98101
- NPI first listed
- 2010-08-23
- NPI last updated
- 2018-01-02
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305